TW200740440A - Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient - Google Patents
Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredientInfo
- Publication number
- TW200740440A TW200740440A TW095123932A TW95123932A TW200740440A TW 200740440 A TW200740440 A TW 200740440A TW 095123932 A TW095123932 A TW 095123932A TW 95123932 A TW95123932 A TW 95123932A TW 200740440 A TW200740440 A TW 200740440A
- Authority
- TW
- Taiwan
- Prior art keywords
- medicaments
- agonists
- treatment
- active ingredient
- additional active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005030733A DE102005030733A1 (de) | 2005-07-01 | 2005-07-01 | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200740440A true TW200740440A (en) | 2007-11-01 |
Family
ID=37087177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095123932A TW200740440A (en) | 2005-07-01 | 2006-06-30 | Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070037781A1 (zh) |
EP (1) | EP1901776B1 (zh) |
JP (1) | JP2009500310A (zh) |
AR (1) | AR054810A1 (zh) |
AT (1) | ATE546159T1 (zh) |
CA (1) | CA2613828A1 (zh) |
DE (1) | DE102005030733A1 (zh) |
TW (1) | TW200740440A (zh) |
WO (1) | WO2007003554A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060035893A1 (en) * | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
TWI385174B (zh) * | 2008-11-10 | 2013-02-11 | Nat Health Research Institutes | 作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物 |
JP2014532063A (ja) * | 2011-10-12 | 2014-12-04 | テリジェン リミテッドTeligene Ltd | キナーゼ阻害剤としてのキナゾリン誘導体およびその使用方法 |
CN106470678A (zh) * | 2014-06-02 | 2017-03-01 | 美迪诺亚公司 | 抑制或治疗纤维化的方法 |
JP2019504850A (ja) * | 2016-02-08 | 2019-02-21 | レデックス ファーマ ピーエルシーRedx Pharma Plc | 複素環式化合物、特に2−オキソ−4,4,5,5,6,6,7,7−オクタヒドロベンズオキサゾール誘導体、および抗菌化合物としてのこれらの使用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2609645A1 (de) * | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
US4570630A (en) * | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FI88112C (fi) * | 1985-07-30 | 1993-04-13 | Glaxo Group Ltd | Anordning foer administrering av laekemedel till patienter |
SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
DE4318455A1 (de) * | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
AU754379B2 (en) * | 1998-08-26 | 2002-11-14 | Smithkline Beecham Corporation | Therapies for treating pulmonary diseases |
TR200402579T4 (tr) | 2000-10-12 | 2004-12-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Kristalin monohidrat, bunun imalat yöntemi ve bir ilaç maddesinin imalatında kullanımı |
DE10050994A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
DE10050995A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
SI1401445T1 (sl) | 2001-06-22 | 2007-02-28 | Boehringer Ingelheim Pharma | Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila |
DE10203741A1 (de) | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
DE10203753A1 (de) | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
DE10203749A1 (de) | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
DE10246374A1 (de) * | 2002-10-04 | 2004-04-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
WO2004047829A1 (en) * | 2002-11-27 | 2004-06-10 | Altana Pharma Ag | New synergistic combination comprising roflumilast and formoterol |
CA2534120C (en) * | 2003-07-31 | 2012-09-11 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising anticholinergics and a betamimetic |
WO2005013945A2 (en) * | 2003-08-05 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising steroids and a betamimetic |
DE102004003428A1 (de) * | 2004-01-23 | 2005-08-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel |
-
2005
- 2005-07-01 DE DE102005030733A patent/DE102005030733A1/de not_active Withdrawn
-
2006
- 2006-06-16 US US11/424,558 patent/US20070037781A1/en not_active Abandoned
- 2006-06-28 EP EP06763946A patent/EP1901776B1/de not_active Not-in-force
- 2006-06-28 AT AT06763946T patent/ATE546159T1/de active
- 2006-06-28 JP JP2008518835A patent/JP2009500310A/ja active Pending
- 2006-06-28 CA CA002613828A patent/CA2613828A1/en not_active Abandoned
- 2006-06-28 WO PCT/EP2006/063650 patent/WO2007003554A1/de not_active Application Discontinuation
- 2006-06-30 TW TW095123932A patent/TW200740440A/zh unknown
- 2006-06-30 AR ARP060102826A patent/AR054810A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2613828A1 (en) | 2007-01-11 |
US20070037781A1 (en) | 2007-02-15 |
EP1901776A1 (de) | 2008-03-26 |
JP2009500310A (ja) | 2009-01-08 |
WO2007003554A1 (de) | 2007-01-11 |
DE102005030733A1 (de) | 2007-01-04 |
ATE546159T1 (de) | 2012-03-15 |
EP1901776B1 (de) | 2012-02-22 |
AR054810A1 (es) | 2007-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200731975A (en) | Novel combinations of medicaments for the treatment of respiratory diseases | |
TW200634003A (en) | Chemical compounds | |
MY143565A (en) | Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof | |
TW200621777A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
TW200616974A (en) | Chemical compounds | |
TW200621262A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
TW200635899A (en) | Chemical compounds | |
MX2007008924A (es) | Compuestos quimicos. | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
TW200621259A (en) | Chemical compounds | |
TW200736234A (en) | Chemical compounds | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
TW200607508A (en) | Powder formulations for inhalation, comprising enantiomerically pure beta agonists | |
MY148945A (en) | Combination of a betamimetic with anticholinergics and/or steroids | |
GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
TW200633978A (en) | 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists | |
TW200626553A (en) | Novel compounds | |
TW200833670A (en) | Novel compounds 569 | |
MY135850A (en) | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | |
TW200510392A (en) | Chemical compounds | |
WO2005037798A3 (en) | Amide or thiomide derivatives and their use in the treatment of pain | |
UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
GB0415365D0 (en) | Pyrimidine derivatives | |
MX2009008084A (es) | Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90. |